Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
Leukemia ; 21(5): 936-42, 2007 May.
Article in English | MEDLINE | ID: mdl-17330103

ABSTRACT

The tyrosine kinase inhibitor imatinib (Gleevec, Novartis Pharmaceuticals Corporation; Basel, Switzerland) is a powerful drug for treatment of chronic myelogenous leukemia (CML) and other malignancies. It selectively targets various tyrosine kinases, thereby leading to growth arrest of respective cancer cells. Given its wide application, it is of high importance to know all related underlying molecular mechanisms. We had previously found that imatinib increases the cellular clearance of intracellular protein aggregates by targeting the abl pathway and thereby upregulating lysosomal activity. Here, we describe that imatinib dose dependently activates the cellular autophagy machinery in mammalian cells, independently of tissue type, species origin or immortalization status of cells. Autophagy is an archetypical cellular degradation mechanism implicated in many physiological and pathophysiological conditions. Our data link for the first time the process of autophagy with the mode of action of imatinib. Induction of autophagy might represent an additional mechanism of imatinib to induce growth arrest, promote apoptosis in cancer cells and eventually even promote tumour regression.


Subject(s)
Antineoplastic Agents/pharmacology , Autophagy/drug effects , Piperazines/pharmacology , Pyrimidines/pharmacology , Animals , Benzamides , Cell Line, Tumor , Dose-Response Relationship, Drug , Imatinib Mesylate , Lysosomes/drug effects , Mice , Phagosomes/drug effects , Proto-Oncogene Proteins c-abl/antagonists & inhibitors , Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors
2.
Br J Dermatol ; 155(1): 119-28, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16792763

ABSTRACT

BACKGROUND: Senile lentigo (SL) is a pigmentation disorder that occurs predominantly on the dorsa of the hands, the forearms and the face; its incidence increases with age. Histological hallmarks of SL lesions are hyperpigmentation of the epidermis and elongation of the epidermal rete ridges. Various factors such as alpha-melanocyte-stimulating hormone, endothelin-1 or stem cell factor are involved in the onset and maintenance of the increased pigmentation. Alterations of the dermal compartment have not yet been analysed in detail in SL. OBJECTIVES: To study the occurrence and distribution of melanin in the dermis from SL and aged skin, biopsies from 12 subjects were morphologically analysed by light and electron microscopy in comparison with unaffected skin. METHODS: Punch biopsies of SL and adjacent skin from 12 male or female volunteers aged 52-81 years were prepared for light and electron microscopy and samples were analysed by morphological, morphometric, histochemical and immunohistochemical methods. RESULTS: The epidermis from SL revealed morphological features such as hyperpigmentation of basal keratinocytes and the formation of elongated rete ridges. S100+ melanocytes in the stratum basale were not markedly increased, indicating that the hyperpigmentation is predominantly due to changes in melanin synthesis, distribution or turnover. Quantification of epidermal cells expressing the proliferation marker Ki67 did not show an increase of this parameter in SL, indicating that at least in the established lesion cell proliferation is not enhanced. We further focused on the dermal compartment and observed granulated cells which were more abundant in SL. Electron microscopic and histochemical analysis revealed that the granulation of these cells is based on melanosomes, mostly present in large melanosomal complexes. Immunohistochemistry using antibodies to CD68 and factor XIIIa (FXIIIa) showed these melanophages to be predominantly FXIIIa+ dermal dendrocytes, which were about six times more abundant than CD68+ macrophages. CONCLUSIONS: In SL an increased number of melanophages was found compared with unaffected skin from the same subject. These melanophages were identified as FXIIIa+ dermal dendrocytes. Possible functional consequences of the massive melanin uptake by dermal dendrocytes are discussed.


Subject(s)
Dermis/metabolism , Epidermis/metabolism , Factor XIIIa/metabolism , Lentigo/metabolism , Melanins/analysis , Skin Aging/physiology , Aged , Aged, 80 and over , Biological Transport , Case-Control Studies , Dermis/pathology , Epidermis/pathology , Female , Humans , Immunohistochemistry/methods , Lentigo/pathology , Male , Melanins/metabolism , Melanosomes/metabolism , Melanosomes/ultrastructure , Microscopy, Electron , Middle Aged , Phagocytosis , Staining and Labeling
3.
Biotechniques ; 30(1): 74-7, 80-1, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11196323

ABSTRACT

Polyethylenimines (PEIs) of a molecular weight between 25 and about 800 kDa have successfully been used for in vitro and in vivo gene delivery approaches. Recent publications indicated that PEI molecules of lower molecular weight and a small molecular weight range are also efficient transfection reagents with a much lower cytotoxicity compared to high molecular weight PEIs. Here, we describe the application of a molecular sieve chromatography to fractionate a commercially available 25-kDa PEI. We generated three pools of PEIs with molecular weight ranges of 70-360 (I), 10-70 (II), and 0.5-10 kDa (III), respectively. We show that, in comparison with the 25-kDa PEI, pool III increased the expression of luciferase up to 100-fold and the number of transfected cells 2-3 fold. In addition, the kinetics of reporter gene expression was also much faster in pool III, compared with the 25-kDa PEI or with pools I or II. Finally, pool III showed the lowest cytotoxicity in comparison with the other PEI preparations. Thus, we provide a one-step processing of a 25-kDa PEI, resulting in a more effective and also less cytotoxic transfection reagent.


Subject(s)
Polyethyleneimine/chemistry , Transfection/methods , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Fluorescence , Molecular Weight , Plasmids/chemistry , Plasmids/genetics , Polyethyleneimine/administration & dosage , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Time Factors , Tumor Cells, Cultured
4.
J Histochem Cytochem ; 49(2): 177-85, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11156686

ABSTRACT

We have recently shown that monodansylcadaverine labels autophagic vacuoles. Analysis of the mechanism underlying the labeling revealed that monodansylcadaverine acts as a lysosomotropic agent, being concentrated into acidic compartments by an ion-trapping mechanism, and as a solvent polarity probe, increasing its relative fluorescence intensity by interacting with membrane lipids that are highly concentrated in the autophagic vacuoles. In this study, we synthesized three structurally related derivatives of monodansylcadaverine, replacing the primary amino group of monodansylcadaverine with a neutral (dansylamylamine; MDH), a polar (dansylaminopentanol; MDOH), or an acidic group (dansylaminovaleric acid; MDA), to replace the lysosomotropic character of the marker. Whereas MDH showed a specific staining of autophagic vacuoles, the polar and acidic derivatives did not show any staining. We further demonstrate that the MDH staining of autophagic vacuoles is independent on the acidic pH and thus on an ion-trapping mechanism, but it still shows the same preferences for autophagic membrane lipids as monodansylcadaverine. We propose that MDH can specifically interact with lamellar bodies of the autophagic type as a solvent polarity probe. Therefore, dansylated aminopentane can be used as a specific marker for autophagic vacuoles in vivo and in fixed cells.(J Histochem Cytochem 49:177-185, 2001)


Subject(s)
Cadaverine/analogs & derivatives , Cadaverine/chemistry , Cell Line , Dansyl Compounds/chemistry , Dansyl Compounds/metabolism , Humans , Microscopy, Fluorescence , Pentanoic Acids/chemistry , Pentanoic Acids/metabolism , Subcellular Fractions/metabolism
5.
EMBO J ; 19(21): 5845-55, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11060035

ABSTRACT

STAT factors act as signal transducers of cytokine receptors and transcriptionally activate specific target genes. The recently discovered protein PIAS3 binds directly to STAT3 and blocks transcriptional activation. Here, we present experimental evidence implementing the zinc finger protein Gfi-1 as a new regulatory factor in STAT3-mediated signal transduction. The interaction between the two proteins first became evident in a yeast two-hybrid screen but was also seen in coprecipitation experiments from eukaryotic cells. Moreover, we found that both Gfi-1 and PIAS3 colocalize in a characteristic nuclear dot structure. While PIAS3 exerts a profound inhibitory effect on STAT3-mediated transcription of target promoters, Gfi-1 can overcome the PIAS3 block and significantly enhances STAT3-mediated transcriptional activation. In primary T cells, Gfi-1 was able to amplify IL-6-dependent T-cell activation. As Gfi-1 is a known, dominant proto-oncogene, our findings bear particular importance for the recently described ability of STAT3 to transform cells malignantly and offer an explanation of the oncogenic potential of Gfi-1 in T lymphocytes.


Subject(s)
Carrier Proteins/metabolism , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Trans-Activators/antagonists & inhibitors , Trans-Activators/metabolism , Transcription Factors , Animals , Carrier Proteins/chemistry , Carrier Proteins/genetics , Cells, Cultured , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Humans , Interleukin-6/pharmacology , Macromolecular Substances , Mice , Mice, Transgenic , Protein Inhibitors of Activated STAT , Proto-Oncogene Mas , STAT3 Transcription Factor , Saccharomyces cerevisiae/genetics , Signal Transduction , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Trans-Activators/genetics , Transcriptional Activation , Transfection , Two-Hybrid System Techniques , Zinc Fingers
6.
Int J Oncol ; 17(5): 1063-9, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11029513

ABSTRACT

Eighty percent of human ovarian and endometrial cancers express receptors for luteinizing hormone-releasing hormone (LHRH). These receptors might be used for targeted chemotherapy with cytotoxic LHRH analogs such as AN-152, in which doxorubicin is linked to agonist carrier [D-Lys6]LHRH. The antiproliferative effects of doxorubicin and AN-152 were assessed in LHRH receptor-positive ovarian (EFO-21, EFO-27) and endometrial (HEC-1A, Ishikawa) cancer cell lines as well as in LHRH receptor negative ovarian SKOV-3 and endometrial MFE-296 lines. The mechanism of action of AN-152 was investigated by a blockage of receptors using an excess of the LHRH agonist [D-Trp6]LHRH. In some cases, confocal laser-scanning microscopy was used to visualize the accumulation of AN-152 or doxorubicin within the cells. In 3 of 4 LHRH receptor-positive cell lines (EFO-21, HEC-1A, Ishikawa) AN-152 was more effective than doxorubicin in inhibiting cell proliferation. The effect of AN-152 was shown to be receptor-mediated because it could be reduced by competitive blockade of the LHRH receptors with [D-Trp6]LHRH. In contrast, AN-152 was less active than doxorubicin in LHRH receptor-negative lines. Confocal laser-scanning microscopy showed an intranuclear accumulation of AN-152 and competitive inhibition thereof by [D-Trp6]LHRH in LHRH receptor-positive cell lines, but no intracellular accumulation of AN-152 could be detected in the receptor-negative SKOV-3 line. These results suggest a selective receptor-mediated action of AN-152 in receptor-positive cell lines.


Subject(s)
Adenocarcinoma/pathology , Antineoplastic Agents/pharmacology , Doxorubicin/analogs & derivatives , Endometrial Neoplasms/pathology , Gonadotropin-Releasing Hormone/analogs & derivatives , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Neoplasm Proteins/drug effects , Neoplasms, Hormone-Dependent/pathology , Ovarian Neoplasms/pathology , Receptors, LHRH/drug effects , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Papillary/pathology , Antineoplastic Agents/metabolism , Biological Transport , Carcinoma, Endometrioid/pathology , Cell Division/drug effects , Cell Nucleus/metabolism , Cystadenocarcinoma, Serous/pathology , Doxorubicin/metabolism , Doxorubicin/pharmacology , Drug Screening Assays, Antitumor , Female , Gonadotropin-Releasing Hormone/metabolism , Gonadotropin-Releasing Hormone/pharmacology , Humans , Microscopy, Confocal , Neoplasm Proteins/physiology , Receptors, LHRH/physiology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology
7.
Differentiation ; 65(5): 287-300, 2000 May.
Article in English | MEDLINE | ID: mdl-10929208

ABSTRACT

In the present study, we show that endothelial-like cells (ELCs) can develop from human CD14-positive mononuclear cells (CD14 cells) in the presence of angiogenic growth factors. The CD14 cells became loosely adherent within 24 h of culture and subsequently underwent a distinct process of morphological transformation to caudated or oval cells with eccentric nuclei. After 1 week in culture the cells showed a clear expression of endothelial cell markers, including von Willebrand factor (vWF), CD144 (VE-cadherin), CD105 (endoglin), acetylated low-density lipoprotein (AC-LDL)-receptor, CD36 (thrombospondin receptor), FLT-1, which is vascular endothelial cell growth factor (VEGF) receptor-1, and, to a weaker extent, KDR (VEGF receptor-2). Furthermore, in these cells structures resembling Weibel-Palade bodies at different storage stages were identified by electron microscopy, and upon culturing on three-dimensional fibrin gels the cells build network-like structures. In addition, cell proliferation and vWF expression was stimulated by VEGF, and the endothelial cell adhesion molecules CD54 (ICAM-1), and CD106 (VCAM-1) became transiently inducible by tumor necrosis factor-alpha (TNF-alpha). In contrast, the dendritic markers CD1a, and CD83 were not expressed to any significant extent. The expression of CD68, CD80 (B7-1), CD86 (B7-2), HLA-DR and CD36 may also suggest that ELCs might be related to macrophages, sinus lining or microvascular endothelial cells. Taken together, our observations indicate that ELCs can differentiate from cells of the monocytic lineage, suggesting a closer relationship between the monocyte/macrophage- and the endothelial cell systems than previously supposed.


Subject(s)
Endothelium/cytology , Lipopolysaccharide Receptors/metabolism , Monocytes/cytology , Antigens, Differentiation/metabolism , Biomarkers/analysis , Cell Differentiation , Cell Line, Transformed , Cells, Cultured , DNA Primers/chemistry , Endothelial Growth Factors/pharmacology , Endothelium/drug effects , Endothelium/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Lymphokines/pharmacology , Microscopy, Electron , Monocytes/drug effects , Monocytes/metabolism , Neovascularization, Physiologic , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
8.
J Biol Chem ; 275(25): 19018-24, 2000 Jun 23.
Article in English | MEDLINE | ID: mdl-10858452

ABSTRACT

LALP70 is a novel lysosomal membrane protein belonging to the apyrase protein family. The apyrase protein family comprises enzymes capable of cleaving nucleotide tri- and diphosphates in a calcium- or magnesium-dependent manner, not being altered by P-type, F-type, or V-type NTPase inhibitors. In this study we have cloned and sequenced the human LALP70 gene to determine the genomic structure. The gene is organized in 11 introns and 12 exons covering a genomic region of approximately 16 kilobase pairs. By fluorescence in situ hybridization analysis, the hLALP70 gene was mapped to the human chromosome 8p21.1-p21.3. We further show that there is at least one alternatively spliced variant, hLALP70v, which can be generated via an alternative splice side at the 3'-end of exon 7, leading to a protein variant differing in 8 amino acids (VSFASSQQ). This is the first splice variant that has been described in the apyrase protein family. Reverse transcriptase polymerase chain reaction analysis showed an ubiquitous expression of both variants, with different relative mRNA expression levels in different tissues. Comparison of the enzymatic properties of the splice variants revealed a broader substrate specificity for hLALP70v with CTP, UDP, CDP, GTP, and GDP as preferred substrates, while hLALP70 utilized UTP and TTP preferentially. Furthermore, enzyme activity of hLALP70v was equally dependent on Ca(2+) and Mg(2+), being saturated already at 1 mm concentration. In contrast, hLALP70 enzymatic activity were unsaturated up to 10 mm Ca(2+), while Mg(2+) showed a saturation at already 1 mm concentration with 2-3-fold lower enzymatic activity as observed with Ca(2+). Our data suggest that the presence or absence of the 8-amino acid motif VSFASSQQ provoke differences in substrate specificity and divalent cation dependence of hLALP70/hLALP70v.


Subject(s)
Apyrase/genetics , Apyrase/metabolism , RNA Splicing , Amino Acid Sequence , Base Sequence , Chromosome Mapping , Cloning, Molecular , DNA, Complementary , Humans , In Situ Hybridization, Fluorescence , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
9.
EMBO J ; 19(4): 655-61, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10675334

ABSTRACT

Sp3 is a ubiquitously expressed transcription factor closely related to Sp1 (specificity protein 1). We have disrupted the mouse Sp3 gene by homologous recombination. Sp3-deficient embryos are growth retarded and invariably die at birth of respiratory failure. The cause for the observed breathing defect remains obscure since only minor morphological alterations were observed in the lung, and surfactant protein expression is indistinguishable from that in wild-type mice. Histological examinations of individual organs in Sp3(-/-) mice show a pronounced defect in late tooth formation. In Sp3 null mice, the dentin/enamel layer of the developing teeth is impaired due to the lack of ameloblast-specific gene products. Comparison of the Sp1 and Sp3 knockout phenotype shows that Sp1 and Sp3 have distinct functions in vivo, but also suggests a degree of functional redundancy.


Subject(s)
DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Odontogenesis/genetics , Odontogenesis/physiology , Transcription Factors/deficiency , Transcription Factors/genetics , Ameloblasts/metabolism , Animals , Animals, Newborn , Base Sequence , DNA Primers/genetics , DNA-Binding Proteins/physiology , Female , Gene Expression , Lung/metabolism , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Phenotype , Pregnancy , Respiratory Insufficiency/genetics , Respiratory Insufficiency/metabolism , Respiratory Insufficiency/pathology , Sp1 Transcription Factor/deficiency , Sp1 Transcription Factor/genetics , Sp1 Transcription Factor/physiology , Sp3 Transcription Factor , Tooth/growth & development , Tooth/metabolism , Tooth/pathology , Transcription Factors/physiology
10.
J Histochem Cytochem ; 48(2): 251-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10639491

ABSTRACT

The autofluorescent substance monodansylcadaverine has recently been reported as a specific in vivo marker for autophagic vacuoles. However, the mechanism for this specific labeling remained unclear. Our results reveal that the common model of ion trapping in acidic compartments cannot completely account for the observed autophagic vacuole staining. Because autophagic vacuoles are characterized by myelin-like membrane inclusions, we tested whether this lipid-rich environment is responsible for the staining properties of monodansylcadaverine. In in vitro experiments using either liposomes or solvents of different polarity, monodansylcadaverine showed an increased relative fluorescence intensity in a hydrophobic environment as well as a Stokes shift dependent on the solvent polarity. To test the effect of autophagic vacuoles or autophagic vacuole lipids on monodansylcadaverine fluorescence, we isolated autophagic vacuoles and purified autophagic vacuole lipids depleted of proteins. Entire autophagic vacuoles and autophagic vacuole lipids had the same effect on monodansylcadaverine fluorescence properties, suggesting lipids as the responsible component. Our results suggest that the in vivo fluorescence properties of monodansylcadaverine do not depend exclusively on accumulation in acidic compartments by ion trapping but also on an effective interaction of this molecule with autophagic vacuole membrane lipids. (J Histochem Cytochem 48:251-258, 2000)


Subject(s)
Cadaverine/analogs & derivatives , Depsipeptides , Fluorescent Dyes/chemistry , Vacuoles/metabolism , 2-Naphthylamine/analogs & derivatives , 2-Naphthylamine/chemistry , Cadaverine/chemistry , Cadaverine/metabolism , Caseins/chemistry , Fluorescent Dyes/metabolism , Humans , Hydrogen-Ion Concentration , Lipids/chemistry , Liposomes/drug effects , Liposomes/metabolism , Peptides, Cyclic/pharmacology , Serum Albumin, Bovine/chemistry , Tumor Cells, Cultured , Vacuoles/drug effects
11.
Hepatogastroenterology ; 46(29): 2751-6, 1999.
Article in English | MEDLINE | ID: mdl-10576340

ABSTRACT

Regeneration from cerulein-induced pancreatitis is accompanied by a transient synthesis and deposition of extracellular matrix components in the rat pancreas. To study the involvement of transforming growth factor beta1 (TGFbeta1), one of the most potent modulators of the extracellular matrix, in the process of pancreatic regeneration we examined the expression of this gene on the transcript and protein level in pancreata of rats sacrificed 0 hours, 24 hours, 2, 3, 5, 7 days after a 12 hour infusion of maximal doses of cerulein (10 microg kg(-1) h(-1)). TGFbeta1 protein increased twofold after 24 hours and 48 hours and returned to control values 7 days after induction of pancreatitis, while TGFbeta1-mRNA reached maximal values (3-fold over controls) after 2 days. The largest amount of TGFbeta1 mRNA was found in pancreatic acinar cells and in stromal cells. To verify the functional implication of TGFbeta overexpression in regulating extracellular matrix remodeling during regeneration from acute pancreatitis, rats were treated with 3 injections of neutralizing antibody against TGFbeta1 given 30 min before, and 24 hours and 48 hours after the start of infusion. In rats treated with maximal doses of cerulein and TGFbeta antibodies, pancreatic hydroxyproline content and expression of collagens I and III and of TGFbeta1 were significantly reduced. These results provide evidence that transforming growth factor beta1 among other cytokines is involved in the regulation of extracellular matrix remodeling in the rat pancreas during regeneration from cerulein-induced acute pancreatitis. In addition, there is evidence in the literature that application of recombinant TGFbeta after recurrent episodes of acute cerulein-induced pancreatitis promotes pancreatic fibrosis (3). Thus, TGFbeta is a regulator of extracellular matrix remodeling in the pancreas, and may be an important promoting factor in the pathogenesis of chronic pancreatitis. This hypothesis is supported by data in the literature showing enhanced TGFbeta expression in human chronic pancreatitis (2) and development of fibrosis and inflammation in pancreata of transgenic mice overexpressing TGFbeta1 (3).


Subject(s)
Extracellular Matrix/physiology , Pancreatitis/physiopathology , Transforming Growth Factor beta/physiology , Acute Disease , Animals , Disease Models, Animal , Extracellular Matrix/pathology , Humans , Mice , Pancreatitis/pathology , Rats , Regeneration/physiology
12.
Pharm Res ; 16(8): 1273-9, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10468031

ABSTRACT

PURPOSE: Low molecular weight branched polyethylenimine (LMW-PEI) was synthesized and studied as a DNA carrier for gene delivery with regard to physico-chemical properties, cytotoxicity, and transfection efficiency. METHODS: The architecture of LMW-PEI, synthesized by acid catalyzed ring-opening polymerization of aziridine was characterized by size exclusion chromatography in combination with laser light scattering and 13C-NMR-spectroscopy. In vitro cytotoxic effects were quantified by LDH and MTT assay and visualized by transmission electron microscopy. The potential for transgene expression was monitored in ECV304 cells using luciferase driven by a SV40 promotor as reporter gene system. RESULTS: LMW-PEI (Mw 11'900 D) with a low degree of branching was synthesized as a DNA carrier for gene delivery. In contrast to high molecular weight polyethylenimines (HMW-PEI; Mw 1'616'000 D), the polymer described here showed a different degree of branching and was less cytotoxic in a broad range of concentrations. As demonstrated by transmission electron microscopy the LMW-PEI formed only small aggregates which were efficiently taken up by different cells in the presence of serum, most likely by an endocytic pathway. LMW-PEI yielded transfection efficiencies measured via expression of the reporter gene luciferase which were up to two orders of magnitude higher than those obtained with HMW-PEI. The reporter gene expression was concentration dependent, but in contrast to lipofection independent of serum addition. CONCLUSIONS: The LMW-PEI described here is a new, highly efficient, and non-cytotoxic vector with a favorable efficiency/toxicity profile for gene therapeutic applications.


Subject(s)
DNA/administration & dosage , Genetic Vectors , Polyethyleneimine/pharmacology , Transfection/methods , Animals , Cells, Cultured , Drug Carriers , Electrophoresis, Agar Gel , Fibroblasts/drug effects , Gene Transfer Techniques , Mice , Molecular Weight , Polyethyleneimine/chemistry , Polyethyleneimine/toxicity
13.
J Cell Sci ; 112 ( Pt 15): 2473-84, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10393803

ABSTRACT

Using antibodies against autophagic vacuole membrane proteins we identified a human cDNA with an open reading frame of 1848 bp, encoding a protein of 70 kDa, which we named lysosomal apyrase-like protein of 70 kDa (LALP70). Sequence analysis revealed that LALP70 belongs to the apyrase or GDA1/CD39 family and is almost identical to a human uridine diphosphatase, with the exception of nine extra amino acids in LALP70. Members of this family were originally described as ectoenzymes, with some intracellular exceptions. Transfected LALP70 fused to the green fluorescent protein localized in the cytoplasm with a punctate pattern in the perinuclear space. These structures colocalized with the autophagic marker monodansylcadaverine and the lysosomal protein lamp1. Hydrophobicity analysis of the encoded protein revealed a transmembrane region at the N and C termini. Most of the sequence is arranged between these transmembrane domains, and contains four apyrase conserved regions. In vitro transcription/translation in the presence of microsomes showed that no signal sequence is cleaved off and that the translation product is protected from trypsin treatment. Our data indicate that LALP70 is a type III lysosomal/autophagic vacuole membrane protein with the apyrase conserved regions facing the luminal space of the vacuoles.


Subject(s)
Lysosomes/ultrastructure , Vacuoles/ultrastructure , Adult , Amino Acid Sequence , Animals , Autophagy , Base Sequence , Conserved Sequence , DNA, Complementary , Female , Fetus , Humans , Lysosomes/metabolism , Male , Mice , Microsomes/ultrastructure , Molecular Sequence Data , Molecular Weight , Open Reading Frames , Protein Biosynthesis , Pyrophosphatases/chemistry , Rats , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Sequence Alignment , Sequence Homology, Amino Acid , Transcription, Genetic , Tumor Cells, Cultured , Vacuoles/metabolism
14.
Oncogene ; 17(20): 2661-7, 1998 Nov 19.
Article in English | MEDLINE | ID: mdl-9840930

ABSTRACT

The gfi-1 gene encodes a zinc finger containing protein that is specifically expressed in T-lymphocytes and is a frequent target of proviral insertion in T-cell lymphoma provoked by infection with MoMuLV--a non acute transforming retrovirus. Expression of a gfi-1 transgene targeted to T-cells by the lck proximal promoter provokes a reduction of peripheral CD4 and CD8 positive T-cells but nevertheless weakly predisposes transgenic animals for the development of T-cell lymphoma. Forced coexpression of the serine/threonine kinase Pim-1 can partially restore normal T-cell numbers in double pim-1/gfi-1 transgenic mice. Moreover, the combinatorial expression of Pim-1 and Gfi-1 leads to accelerated development of T-cell lymphoma with a mean latency period of 114 days. A similar accelerated rate of lymphoma development was observed when lck-gfi-1 mice were crossed with mice that carry a L-myc gene targeted to be expressed at high levels in T-cells. The results show that gfi-1 can act with low activity as a dominant oncogene when overexpressed but also demonstrate that it is most efficient only in the presence of a cooperative partner protein as for example Pim-1 or L-Myc. In addition, the results suggest that Pim-1 and Gfi-1 are acting synergistically in both T-cell lymphomagenesis and T-cell development.


Subject(s)
Cell Transformation, Neoplastic/genetics , DNA-Binding Proteins/physiology , Genes, myc , Lymphoma, T-Cell/genetics , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins c-myc/physiology , Proto-Oncogene Proteins/physiology , T-Lymphocytes/metabolism , Transcription Factors , Zinc Fingers/physiology , Age of Onset , Animals , Crosses, Genetic , DNA-Binding Proteins/genetics , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/genetics , Lymphoid Tissue/cytology , Lymphoma, T-Cell/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Promoter Regions, Genetic , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-pim-1 , Recombinant Fusion Proteins/physiology , Zinc Fingers/genetics
15.
Eur J Cell Biol ; 76(4): 251-64, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9765055

ABSTRACT

A cell line (PaTu 8902LM) exhibiting an altered phenotypic appearance was selected from a highly dedifferentiated established human pancreatic tumour cell line (PaTu 8902) by repetitive exposure to laminin-1/nidogen substratum and subsequent selection for adherent cells. Polymerase chain reaction analysis for repetitive DNA indicated that both cell lines are genetically very closely related. The original PaTu 8902 line consisted of flat cells growing in monolayers. In contrast, the obtained PaTu 8902LM cells exhibited a spherical morphology and tended to form clusters. Immunofluorescence analysis using antibodies against apical and basolateral marker enzymes indicated that the PaTu 8902LM cells were polarized, arranging their apical surfaces around central lumenal structures when growing in clusters. In addition, the selected PaTu 8902LM cell line exhibited altered levels of a number of differentiation marker enzymes like 5'-nucleotidase, transglutaminase and plasminogen activators. The different morphological characteristics of both cell lines were maintained even after injection into nude mice. In xenografts, PaTu 8902LM cells were grouped around lumenal, duct-like structures, whereas the original PaTu 8902 cell line formed solid tumours composed of undifferentiated cells. Evidence is presented that the PaTu 8902LM cells are not merely selected from preexisting cells, but that the exposure of PaTu 8902 cells to laminin-1/nidogen had induced a stable transdifferentiation towards the phenotype of the epithelial cells lining the pancreatic secretory ducts. Thus the PaTu 8902LM cells resemble more closely those cells from which tumours of the pancreas originate in vivo and therefore might be a useful cell system in future analyses of the biology of pancreatic tumours which are of increasing incidence and clinical importance.


Subject(s)
Adenocarcinoma , Laminin/pharmacology , Membrane Glycoproteins/pharmacology , Pancreatic Neoplasms , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Adhesion/drug effects , Cell Membrane/chemistry , Cell Membrane/enzymology , Cell Polarity/physiology , Chromosomes/chemistry , Colchicine/pharmacology , Cytoskeleton/chemistry , Endopeptidases/analysis , Endopeptidases/metabolism , Extracellular Matrix/chemistry , Extracellular Matrix/enzymology , Fluorescent Antibody Technique , Gene Expression Regulation, Neoplastic , Humans , Mice , Mice, Nude , Microscopy, Electron , Microtubules/chemistry , Microtubules/drug effects , Neoplasm Proteins/analysis , Neoplasm Proteins/genetics , Phenotype , Rabbits , Transplantation, Heterologous , Tumor Cells, Cultured/chemistry , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/ultrastructure , Vacuoles/chemistry , Vinblastine/pharmacology
16.
EMBO J ; 17(18): 5349-59, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9736613

ABSTRACT

After rearrangement of the T-cell receptor (TCR) beta-locus, early CD4(-)/CD8(-) double negative (DN) thymic T-cells undergo a process termed 'beta-selection' that allows the preferential expansion of cells with a functional TCR beta-chain. This process leads to the formation of a rapidly cycling subset of DN cells that subsequently develop into CD4(+)/CD8(+) double positive (DP) cells. Using transgenic mice that constitutively express the zinc finger protein Gfi-1 and the serine/threonine kinase Pim-1, we found that the levels of both proteins are important for the correct development of DP cells from DN precursors at the stage where 'beta-selection' occurs. Analysis of the CD25(+)/CD44(-,lo) DN subpopulation from these animals revealed that Gfi-1 inhibits and Pim-1 promotes the development of larger beta-selected cycling cells ('L subset') from smaller resting cells ('E subset') within this subpopulation. We conclude from our data that both proteins, Pim-1 and Gfi-1, participate in the regulation of beta-selection-associated pre-T-cell differentiation in opposite directions and that the ratio of both proteins is important for pre-T-cells to pass the 'E' to 'L' transition correctly during beta-selection.


Subject(s)
Cell Cycle Proteins , DNA-Binding Proteins/physiology , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/physiology , Receptors, Antigen, T-Cell, alpha-beta/immunology , T-Lymphocytes/immunology , Transcription Factors , Tumor Suppressor Proteins , Animals , CD4 Antigens/analysis , CD8 Antigens/analysis , Cell Differentiation , Crosses, Genetic , Cyclin-Dependent Kinase Inhibitor p27 , DNA-Binding Proteins/analysis , Gene Rearrangement, T-Lymphocyte , Genes, bcl-2 , Hyaluronan Receptors/analysis , Leukopoiesis , Mice , Mice, Transgenic , Microtubule-Associated Proteins/analysis , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins c-pim-1 , Receptors, Interleukin-2/analysis , T-Lymphocytes/chemistry , Thymus Gland
17.
Clin Cancer Res ; 2(9): 1607-18, 1996 Sep.
Article in English | MEDLINE | ID: mdl-9816340

ABSTRACT

To explore the putative role of hyaluronan (HA) in tumor invasion in pancreatic cancer, we investigated the expression of the HA receptors CD44s and RHAMM in a panel of human pancreatic cancer cell lines. Expression of CD44s has been found in only 1 of 10 cell lines included in this study. This cell line exhibits a highly differentiated phenotype without any metastatic potential when injected into nude mice. Since it has previously been shown that normal pancreatic duct cells express a high level of CD44s, our results indicate that pancreatic cancer may be accompanied by an almost complete loss of CD44s expression. As demonstrated by PCR amplification, this loss of CD44s expression is due to alternative splicing of CD44 pre-RNA. Although most of the pancreatic cancer cell lines express a complex but identical pattern of variant CD44 gene transcripts, only one higher molecular weight CD44 isoform can be detected in a subset of pancreatic cancer cell lines in Western blot analysis. This variant CD44 molecule represents the epithelial CD44 isoform (CD44v8-v10). When cells are cultured on Matrigel, the expression of additional CD44 variants is induced, suggesting that the extracellular matrix can influence the expression of CD44 isoforms and thereby may facilitate tumor invasion. This induction could be due to a regulatory process in the translation of the CD44 variant mRNAs expressed in pancreatic tumor cells. Molecular cloning of a cDNA encoding human RHAMM reveals that both HA receptors are structurally unrelated. In addition, they share an inverse expression pattern. RHAMM mRNA is overexpressed in pancreatic cancer cell lines exhibiting a poorly differentiated phenotype and a high metastatic potential when injected into nude mice. These results indicate that CD44 and RHAMM differentially contribute to invasion of pancreatic adenocarcinoma; however, these functions still remain to be determined.


Subject(s)
Extracellular Matrix Proteins/genetics , Hyaluronan Receptors/genetics , Pancreatic Neoplasms/genetics , 3T3 Cells , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , DNA, Complementary/chemistry , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Extracellular Matrix Proteins/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Genetic Variation , Humans , Immunohistochemistry , Mice , Mice, Nude , Molecular Sequence Data , Neoplasm Transplantation , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , RNA, Messenger/genetics , RNA, Neoplasm/analysis , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism
18.
J Biochem ; 119(2): 378-84, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8882734

ABSTRACT

Since it was considered that an active immunization against ganglioside Gfpt1 (IV2Fuc-, II3NeuAc-Gg4Cer) expressed by human small cell lung cancer cells may be beneficial in the treatment of this neoplasm in humans, an optimal mode of vaccination in model mice was investigated. A novel Gfpt1-muramyldipeptide conjugate (Gfpt1-MDP) was synthesized. Its ganglioside carbohydrate-directed immunogenicity in mice as measured by serum antibody titers was comparable to that of the previously described Gfpt1-keyhole limpet hemocyanin conjugate (Gfpt1-KLH). Similar immunogenicity was displayed by free Gfpt1 in muramyldipeptide-phosphoethanolamine-containing phosphatidyl-choline, -serine (PC,PS) liposomes. Immunization with Gfpt1-vaccines in the presence of monophosphoryllipid A (MPL), in general, raised titers of anti-Gfpt1 antibodies effectively. Immunization with PC, PS-liposomes containing unconjugated Gfpt1 and MPL stimulated the highest titers observed, thereby effectively preventing tumor growth in Balbc nu/nu-mice challenged with human small cell lung cancer cells. However, there was a strong crossreaction of these and most other sera with the structurally related and widely distributed ganglioside Gtet1 (II3NeuAc-Gg4Cer). Only immunization with Gfpt1-KLH conjugate in the presence of MPL stimulated selectively high anti-Gfpt1 antibody titers showing comparably low crossreactivity to ganglioside Gtet1.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Dipeptides/administration & dosage , G(M1) Ganglioside/analogs & derivatives , Hemocyanins/administration & dosage , Lipid A/analogs & derivatives , Animals , Carcinoma, Small Cell/immunology , Carcinoma, Small Cell/pathology , G(M1) Ganglioside/administration & dosage , Lipid A/pharmacology , Lung Neoplasms/immunology , Lung Neoplasms/pathology , Mice , Tumor Cells, Cultured
19.
Pancreas ; 11(2): 154-9, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7479672

ABSTRACT

Silver staining of nucleolar organizer regions (AgNORs) demonstrates loops of DNA that transcribe ribosomal RNA. Their number and size have been attributed to rDNA transcription activity involved in protein synthesis and thus associated with proliferation. The exact relationship among proliferation, protein synthesis, and expression of AgNORs is, however, not yet well established. We therefore investigated AgNORs in an experimental model of cerulein-induced rat pancreatitis. During secretory stimulation with maximal doses of cerulein (0.25 micrograms/kg/h) for 12 h, AgNOR number and size per nucleus as well as 3H-thymidine label index did not change, although there was a marked increase in pancreatic volume flow, up to 150%, and of protein synthesis rate, up to 180% of the control levels. In contrast, after infusion of supramaximal doses of cerulein (5.0 micrograms/kg/h), AgNOR and 3H-thymidine label values rose significantly, with a distinct peak at day 3 after induction of pancreatitis. Most interestingly, AgNOR number and size were elevated 12 h before DNA replication started as determined by 3H-thymidine incorporation. At the same time intracellular protein synthesis proved to be decreased approximately 30-50% compared to controls. Our data confirm that AgNOR is a marker of proliferation that reflects regulatory events in the cell cycle earlier than 3H-thymidine incorporation. Here we demonstrate for the first time that this phenomenon is independent of the total intracellular protein synthesis rate.


Subject(s)
Nucleolus Organizer Region/ultrastructure , Pancreas/physiopathology , Pancreas/ultrastructure , Pancreatitis/pathology , Acute Disease , Animals , Cell Division , Ceruletide , DNA/biosynthesis , Male , Pancreatitis/chemically induced , Pancreatitis/physiopathology , RNA, Ribosomal/metabolism , Rats , Rats, Wistar , Regeneration , Silver Staining , Transcription, Genetic
20.
J Physiol ; 485 ( Pt 1): 167-77, 1995 May 15.
Article in English | MEDLINE | ID: mdl-7658371

ABSTRACT

1. The roles of the gamma-glutamyl cycle and the anionic amino acid transport system xc- in mediating L-cystine uptake were investigated in cultured human pancreatic duct PaTu 8902 cells. This cell line exhibits morphological features of normal pancreatic duct cells and expresses gamma-glutamyl transpeptidase (gamma-GT, EC 2.3.2.2), an enzyme involved in the metabolism and regulation of intracellular glutathione (GSH). 2. Uptake of L-cystine (10 microM) was linear for up to 10 min, temperature dependent, Na+ independent, saturable (Michaelis-Menten constant (Km), 86 +/- 25 microM; maximal velocity (Vmax), 109 +/- 33 nmol (mg protein)-1 h-1) and reduced by 80-90% by a 50-fold excess concentration of L-glutamate and L-homocysteic acid, but not L-aspartate. These transport properties resemble those described for system xc-, which exchanges cystine for intracellular glutamate. 3. Acivicin, a known inhibitor of gamma-GT, decreased gamma-GT activity from 2.58 +/- 0.96 to 0.97 +/- 0.11 mU (mg protein)-1 and decreased the initial rates of L-cystine and L-glutamine uptake by 41-55%. Anthglutin (1-gamma-L-glutamyl-2-(2-carboxyphenylhyl)hydrazine), a structurally different inhibitor of gamma-GT, also caused a concentration-dependent (0.01-1 mM) decrease in gamma-GT activity and L-cystine uptake. 4. Neither acivicin nor anthglutin inhibited the uptake of L-glutamate, a poor substrate for gamma-GT. 5. In the presence of a 500-fold excess concentration of glutamate, which should abolish entry of cystine via system xc-, the remaining fraction of cystine transport was inhibited by 50% by acivicin, suggesting that transport is, in part, dependent on the activity of gamma-GT. 6. Cystine transport was also 60-80% inhibited by a series of gamma-glutamyl amino acids (5 mM) including gamma-glutamyl-glutamate, gamma-glutamyl-glutamine and gamma-glutamyl-glycine. alpha-Dipeptides inhibited cystine transport by only 6-22%. 7. These findings demonstrate that in human pancreatic duct PaTu 8902 cells, cystine uptake is mediated by system xc- (50-60%) and the gamma-glutamyl cycle. Our results provide the first evidence linking gamma-GT with cystine transport in human epithelial cells and are of relevance in view of the importance of cystine as a sulphur amino acid source for GSH synthesis in cells exposed to oxidative stress.


Subject(s)
Amino Acids/metabolism , Cystine/metabolism , Pancreatic Ducts/metabolism , gamma-Glutamyltransferase/physiology , Adenosine Triphosphate/metabolism , Cell Line , Glutamates/pharmacology , Humans , Isoxazoles/pharmacology , Kinetics , Microscopy, Electron , Microscopy, Electron, Scanning , Pancreatic Ducts/cytology , Pancreatic Ducts/ultrastructure , Pyrrolidonecarboxylic Acid/pharmacology , gamma-Glutamyltransferase/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...